Home

The US Treasury Department has issued proposed regulations to implement the Comprehensive Outbound Investment National Security Act (COINS Act), which would expand the existing Outbound Investment Security Program to cover additional technology sectors including biotechnology. Meanwhile, China's Ministry of Commerce (MOFCOM) and Ministry of Science and Technology have issued a notice soliciting public comments on proposed revisions to China's technology export control catalogue (Announcement No. 48). The proposed revisions cover 40 technologies across three sectors, including biopharmaceuticals, artificial intelligence and photovoltaics. These regulatory developments could have significant implications for cross-border investment, technology transfers, and licensing activities.


The American Chamber of Commerce in Shanghai's Healthcare Committee and Legal Committee will jointly host an online session on Tuesday, November 24, from 10:00 AM to 11:00 AM. John Tan, Partner, and Alex Wang, China Counsel, at Arnold & Porter LLP will provide an overview of these regulatory developments and discuss their potential implications for US healthcare and pharmaceutical companies operating in China.


Virtual Attendance: If you plan to join online, please select the "Join Virtually" ticket. A Zoom link will be sent to registered participants one day before the event.

Speakers

  • John Tan (Partner at Arnold & Porter LLP)

    John Tan

    Partner at Arnold & Porter LLP

    As the Co-Lead of the firm’s Anti-Corruption practice, John Tan counsels clients on internal and government investigations, privacy and cybersecurity matters, and corporate compliance.

    John brings a cross-disciplinary and cross-cultural perspective to his work, drawing on his experience as a trial and appellate lawyer and as in-house investigative counsel. He has advised clients across multiple industries and has particular experience in the life sciences and healthcare, automotive, and energy sectors. Clients describe John as "detailed" and "meticulous," and having "a very in-depth view of the Chinese legal system." His work includes counseling companies on the Foreign Corrupt Practices Act and other anti-corruption regulations, responding to government inquiries, developing compliance programs, and conducting compliance due diligence for corporate transactions. John also advises companies on privacy compliance and the creation of cross-border data strategies and assists companies in conducting data security and cybersecurity reviews.

    view more
  • Alex Wang (China Counsel at Arnold & Porter LLP)

    Alex Wang

    China Counsel at Arnold & Porter LLP

    Alex Wang advises pharmaceutical, biotechnology, medical device, and healthcare companies on regulatory, compliance, and transactional matters, including cross-border collaboration, technology transfer and licensing, market access and commercialization strategies, advertising and promotion, post-market compliance, and China’s human genetic resources regulations. Mr. Wang also advises public and private multinational companies on a wide range of issues, including mergers and acquisitions, foreign direct investment, labor and employment, corporate governance, and compliance with PRC laws.

    Alex obtained his LL.M. degree from Washington University in St. Louis School of Law (USA). He also received his LL.B. and LL.M. degrees from Fudan University School of Law (China). He is admitted to the Bar of the State of New York and has also passed the PRC Bar. Before joining the firm in 2010, he worked at the Shanghai offices of two major U.S. law firms. Mr. Wang is a native speaker of Mandarin and is fluent in English.

    view more

Tickets

A prepayment is required when choosing 'Standard Price'.

“ๆ ‡ๅ‡†็ฅจไปท”่ฆๆฑ‚ๆ‚จๅœจๆไบคๆณจๅ†ŒไฟกๆฏๅŽๅณๅˆปๅฎŒๆˆๅœจ็บฟ้ข„ไป˜๏ผŒ่‹ฅๆ‚จๅธŒๆœ›ๅœจๆดปๅŠจ็Žฐๅœบๆ”ฏไป˜้—จ็ฅจ๏ผŒ่ฏท้€‰ๆ‹ฉ“็Žฐๅœบ็ฅจไปท”ใ€‚
Webinar: Member Ticket (Online)
Member Price Complimentary
Webinar: Member Company Employee Ticket (Online)
Standard Price RMB 200
Webinar: Non-member Ticket (Online)
Standard Price RMB 500